Differentiation of renal oncocytoma and clear-cell renal cell carcinomas by MSCT
CHEN Shang-chao1, CHEN Yu1, YANG Yun-jun2, XIA Neng-zhi2, LIN Bo-li2, HUANG Ying-bao2
1. Wenzhou Central Hospital, Wenzhou Zhejiang 325000, China;
2. The First Affiliated Hospital of Wenzhou Medical University, Wenzhou Zhejiang 325000, China)
Abstract：Objective: To discuss the value of 4 phase MSCT in distinguishing renal oncocytoma(RO) from clear-cell renal cell carcinomas(ccRCC)． Methods: Eighty masses from 79 patients underwent plain and enhanced CT scans due to renal mass. Twenty-nine cases of RO and fifty cases of ccRCC were confirmed by pathology. The imaging findings of the two groups were retrospectively analyzed. Attenuation values, corrected attenuation values in 4 phases, differences of the attenuation values between cortical phase and nephrographic phase, enhance clearance rates were analyzed by the Student’s t-test in SPSS 19.0 software. Locations, shapes, characteristics of plain scan, degrees of enhancement, patterns of enhancement, differences of the attenuation values between cortical phase and nephrographic phase and segmental enhancement inversions were analyzed by the Fisher’s exact test. Results: There were statistically significant differences between RO and ccRCC in attenuation values and corrected attenuation values in cortical phase, differences of the attenuation values between cortical phase and nephrographic phase, enhance clearance rates(P＜0.05). The attenuation values and corrected attenuation values in unenhancement scan, nephrographic phase and excretory phase had no statistically significant differences between RO and ccRCC(P＞0.05).There were statistically significant differences between RO and ccRCC in central stellate low densities,degrees of enhancement, homogeneous degree of enhancement, spoke-wheel-like enhancement, differences between the attenuation values in cortical phase and nephrographic phase and segmental enhancement inversions(P＜0.05). Positions, shapes, calcifications, flocculent and streaky shadowings around the lesions had no statistically significant differences between RO and ccRCC(P＞0.05). Conclusion: MSCT shows important value in preoperative distinguishing RO from ccRCC. The attenuation values and corrected attenuation values in cortical phase, differences between the attenuation values in cortical phase and nephrographic phase, enhancement clearance rates, central stellate low densities, degrees of enhancement, homogeneous degree of enhancement, spoke-wheel-like enhancement, differences between the attenuation values in cortical phase and nephrographic phase and segmental enhancement inversions can contribute to the differentiation of the RO and ccRCC.
陈上超1，陈 宇1，杨运俊2，夏能志2，林博丽2，黄颖宝2. MSCT对肾脏嗜酸细胞腺瘤和透明细胞癌的鉴别诊断价值[J]. 中国临床医学影像杂志, 2020, 31(2): 123-127.
CHEN Shang-chao1, CHEN Yu1, YANG Yun-jun2, XIA Neng-zhi2, LIN Bo-li2, HUANG Ying-bao2. Differentiation of renal oncocytoma and clear-cell renal cell carcinomas by MSCT. JOURNAL OF CHINA MEDICAL IMAGING, 2020, 31(2): 123-127.
[1]Lopez-Beltran A, Scarpelli M, Montironi R, et al. 2004 WHO classification of the renal tumors of the adults[J]. Eur Urol, 2006, 49(5): 798-805.
[2]Ching BC, Tan HS, Tan PH, et al. Differential radiologic characteristics of renal tumours on multiphasic computed tomography[J]. Singapore Med J, 2017, 58(5): 262-266.
[3]Gakis G, Kramer U, Schilling D, et al. Small renal Oncocytomas: Differentiation with multiphase CT[J]. Eur J Radiol, 2011, 80(2): 274-278．
[4]Alshumrani G, O’Malley M, Ghai S, et al. Small(<4cm) cortical renal tumors: characterization with multidetector CT[J]. Abdom Imaging, 2010, 35(4): 488-493．
[5]Ren A, Cai F, Shang YN, et al. Differentiation of Renal Oncocytoma and Renal Clear Cell Carcinoma Using Relative CT Enhancement Ratio[J]. Chin Med J(Engl), 2015, 128(2): 175-179.
[6]Bird VG, Kanagarajah P, Morillo G, et al. Differentiation of oncocytoma and renal cell carcinoma in small renal masses(<4cm): the role of 4-phase computerized tomography[J]. World J Urol, 2011, 29(6): 787-792．
[7]张亚楠. 应用MDCT多期扫描鉴别小肾肿瘤的研究[D]. 天津：天津医科大学，2014．
[8]Pierorazio PM, Hyams ES, Tsai S, et al. Multiphasic Enhancement Patterns of Small Renal Masses(<4cm) on Preoperative Computed Tomography: Utility for Distinguishing Subtypes of Renal Cell Carcinoma, Angiomyolipoma, and Oncocytoma[J]. Urology, 2013, 81(6): 1265-1272.
[9]何为，刘剑羽. 肾嗜酸细胞腺瘤与透明细胞癌的多期螺旋CT增强特征对比研究[J]. 中华放射学杂志，2011，45（12）：1203-1206.
[10]尚燕宁，蔡丰，任安，等. CT相对强化比值鉴别肾嗜酸性细胞瘤与肾透明细胞癌的应用价值[J]. 放射学实践，2016，31（2）：159-162.
[11]陈穹，汪茂文，路明，等. 肾嗜酸细胞腺瘤的MDCT诊断[J]. 中国医学计算机成像杂志，2014，20（2）：147-151.
[12]单连强，沈龙山，石祖强，等. 64排螺旋CT在肾透明细胞癌诊断中的价值[J]. 中华全科医学，2015，13（5）：797-799.
[13]Woo S, Cho JY, Kim SH, et al. Segmental Enhancement Inversion of Small Renal Oncocytoma: Differences in Prevalence.According to Tumor Size[J]. AJR, 2013, 200(5): 1054-1059.
[14]McGahan JP, Lamba R, Fisher J. Is Segmental Enhancement Inversion on Enhanced Biphasic MDCT a Reliable Sign for the Noninvasive Diagnosis of Renal Oncocytomas[J]. AJR, 2011, 197(4): 674-679.
[15]陈兴发，陈晓丹，王运韬，等. 肾嗜酸性细胞腺瘤的MSCT表现与病理对照研究[J]. 中国CT和MRI杂志，2018，16（8）：107-110.
[16]马丽娅，胡道予，李佳丽，等. 小肾嗜酸细胞腺瘤的CT增强表现及与小肾透明细胞癌的鉴别[J]. 放射学实践，2018，33（7）：731-736.
[17]吴佩军，李伟，华婷，等. 肾透明细胞癌CT表现与病理[J]. 上海医学，2010，33（3）：284-287.
2020, Vol. 31 
